Issue of Equity & Director/PDMR Shareholding
For immediate release |
|
SOPHEON PLC
("Sopheon" or the "Company")
Issue of Equity
PDMR Shareholding
Sopheon plc, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, announces that, following the exercise of options by several employees, it has issued and allotted 24,000 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 15 June 2020 ("Admission").
The options that have been exercised were due to expire on 27 August 2020, and had an exercise price of £1.50 per Ordinary Share. They include options for 7,500 Ordinary Shares that have been exercised by a director, Arif Karimjee, and the resulting Ordinary Shares have been sold at a price of £7.10 per share. These options were not granted under a tax-sheltered scheme, and accordingly carry a tax and national insurance liability due upon exercise. Following this transaction, Arif Karimjee's total beneficial interest in Ordinary Shares, including those held by his spouse, remains unchanged at 82,493 Ordinary Shares.
The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,202,138. The Company does not hold any shares in treasury. Accordingly, the figure of 10,202,138 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information contact:
|
Barry Mence, Chairman |
Sopheon plc |
+ 44 (0) 1276 919 560 |
|
Carl Holmes/Giles Rolls (Corporate Finance) Alice Lane (ECM) |
finnCap |
+ 44 (0) 20 7220 0500 |
About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
|
a) |
Name |
Arif Karimjee |
||||||||
|
2. |
Reason for the Notification |
|||||||||
|
a) |
Position/status |
PDMR |
||||||||
|
b) |
Initial notification/Amendment |
|
||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name |
Sopheon plc |
||||||||
|
b) |
LEI |
213800TA9E6UG2WWG646 |
||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the Financial instrument, type of instrument |
|
||||||||
|
Identification code |
GB00BSZM1369 |
|||||||||
|
b) |
Nature of the transaction |
|
||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||
|
d) |
Aggregated information: · Aggregated volume · Price |
As per 4(c) above |
||||||||
|
e) |
Date of the transaction |
9 June 2020 |
||||||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |
||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 21 minutes ago Tertiary Minerals
- 21 minutes ago Hargreaves Services
- 13 hours ago ASOS
- 13 hours ago MJ Gleeson
- 13 hours ago Rolls-Royce Holdings